ABMC Stock Overview
Engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
American Bio Medica Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 9,900.00% |
| 1 Year Change | -50.00% |
| 3 Year Change | -99.70% |
| 5 Year Change | -99.86% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABMC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | -0.4% |
| 1Y | -50.0% | 10.5% | 24.8% |
Return vs Industry: ABMC underperformed the US Medical Equipment industry which returned 10.1% over the past year.
Return vs Market: ABMC underperformed the US Market which returned 23.9% over the past year.
Price Volatility
| ABMC volatility | |
|---|---|
| ABMC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ABMC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ABMC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 20 | n/a | www.abmc.com |
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat.
American Bio Medica Corporation Fundamentals Summary
| ABMC fundamental statistics | |
|---|---|
| Market cap | US$4.81k |
| Earnings (TTM) | US$850.00k |
| Revenue (TTM) | US$726.00k |
0.0x
P/E Ratio0.0x
P/S RatioIs ABMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABMC income statement (TTM) | |
|---|---|
| Revenue | US$726.00k |
| Cost of Revenue | US$873.00k |
| Gross Profit | -US$147.00k |
| Other Expenses | -US$997.00k |
| Earnings | US$850.00k |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ABMC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 04:22 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
American Bio Medica Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|